FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Priority Review for Orca Blood Cancer Cell Therapy

FDA accepts for priority review an Orca Bio BLA for Orca-T, an investigational allogeneic T-cell immunotherapy for patients with certain blood cancers...

latest-news-card-1
Medical Devices

FDA Authorizes Cryoablation for Low-Risk Breast Cancer

FDA grants IceCure Medicals de novo marketing authorization for the ProSense cryoablation system for treating early-stage, low-risk breast cancer in w...

latest-news-card-1
Human Drugs

5 Items in Dr. Reddys Form FDA-483

FDA issues Dr. Reddy's Laboratories a five-item Form FDA-483 after inspecting the firms drug substance and drug product manufacturing facility last mo...

latest-news-card-1
Human Drugs

Datroway Positive Data in Breast Cancer Patients

AstraZeneca and Daiichi Sankyo report new data showing that their antibody-drug conjugate Datroway (datopotamab deruxtecan) significantly improved sur...

latest-news-card-1
Human Drugs

Abivax Positive Data with Ulcerative Colitis Drug

Abivax announces new Phase 3 data showing that its lead drug candidate, obefazimod, achieved clinically meaningful improvements across all efficacy en...

latest-news-card-1
Human Drugs

FDA OKs Arcutis Zoryve for Pediatric Eczema

FDA approves an Arcutis Biotherapeutics supplemental NDA for Zoryve (roflumilast) cream 0.05% for treating mild to moderate atopic dermatitis in child...

Human Drugs

FDA Pilots Speedier Reviews for U.S.-Made Generics

FDA unveils a new pilot program to prioritize the review of certain generic drug ANDAs in an effort to boost domestic pharmaceutical manufacturing and...

latest-news-card-1
Human Drugs

Makary Outlines Push to Modernize Drug Reviews

FDA commissioner Marty Makary talks with CNNs Sanjay Gupta and says he wants to speed up the nations drug approval process without compromising safety...

latest-news-card-1
Human Drugs

Brookings Questions FDAs New Voucher Program

A new Brookings Institution commentary raises concerns about FDAs new Commissioners National Priority Voucher pilot program.

latest-news-card-1
Human Drugs

2nd Generic Mifepristone Approved, Prompting Backlash

FDA approves the second generic copy of abortifacient mifepristone, a move that prompted mixed reactions from lawmakers and advocacy groups.